"Addition of Bevacizumab to the Treatment of Newly Diagnosed Glioblastoma Brain Tumors Does Not Extend Patients’ Lives," Healthcanal.com

This study was led by representatives from The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute and The University of Texas MD Anderson Cancer Center - two of the 23 NCCN Member Insti...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news